These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 5311447)

  • 21. [What can we expect from an anti-inflammatory agent after 3 years of experimentation and rheumatologic practice?].
    Weissenbach R
    Therapeutique; 1972 Dec; 48(10):685-8. PubMed ID: 4540974
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of degenerative rheumatic diseases. Therapy of painful irritation-conditions of the spine and of periarthrosis using a new combination preparation].
    Gerhold H
    Fortschr Med; 1974 Aug; 92(22):958-61. PubMed ID: 4547109
    [No Abstract]   [Full Text] [Related]  

  • 23. [External therapy of degenerative inflammatory diseases of muscles and joints].
    Wischmann H
    Fortschr Med; 1973 Jun; 91(18):799-800. PubMed ID: 4541880
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences with calcium bumadizone].
    Driessens M; Mortier G; De Ridder AJ
    Acta Belg Med Phys; 1983; 6(1):37-40. PubMed ID: 6227180
    [No Abstract]   [Full Text] [Related]  

  • 25. ["Double-blind" clinical study of a non-steroid anti-inflammatory drug: glucametacine].
    Pipino F; Franchin F
    Minerva Med; 1980 Oct; 71(39):2845-50. PubMed ID: 7001282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Meprotixol (N 7020). Studied in rheumatic diseases in a double blind multicenter investigation in general practice].
    Kogstad O; Apall-Olsen P; Fjerdingstad S; Garfelt R; Helgesen RO; Joheim I; Klaastad R; Rosenberg I; Selvåg J; Toreid K; Tonnessen JS
    Tidsskr Nor Laegeforen; 1974 Feb; 94(4):209-12. PubMed ID: 4595468
    [No Abstract]   [Full Text] [Related]  

  • 27. [Controlled clinical experimentation of a new synthetic preparation (MY 41-6) with anti-inflammatory, antalgic and myorelaxant effect].
    Capretti G; Marinoni C
    Clin Ter; 1974 Feb; 68(3):233-45. PubMed ID: 4596251
    [No Abstract]   [Full Text] [Related]  

  • 28. [Value of pyrazinobutazone in the treatment of different inflammatory states].
    Gaillarde B; Ortonne JP; Pugeat M; Plauchu M
    J Med Lyon; 1972 Oct; 53(234):1315-6 passim. PubMed ID: 4539046
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experience on the antirheumatic activity of a new compound with anti-inflammatory and analgesic properties: Febutol I.S.M].
    Andreotti L; Giardina A
    Minerva Med; 1967 Apr; 58(32):1429-35. PubMed ID: 5298352
    [No Abstract]   [Full Text] [Related]  

  • 30. [The anti-inflammatory clinical effects of pyrazinobutazone (study of 44 cases with principally rheumatologic indications)].
    Le Chevallier PL
    Rhumatologie; 1972 Mar; 24(3):91-100. PubMed ID: 4538813
    [No Abstract]   [Full Text] [Related]  

  • 31. [Meprotixol (N 7020). Clinical experiences in rheumatic diseases].
    Kogstad O
    Tidsskr Nor Laegeforen; 1974 Feb; 94(4):212-4. PubMed ID: 4595469
    [No Abstract]   [Full Text] [Related]  

  • 32. [Multicenter study of Felden 20 suppositories in 3887 patients].
    von Criegern T
    Med Welt; 1983 Nov; 34(45):1290-3. PubMed ID: 6358773
    [No Abstract]   [Full Text] [Related]  

  • 33. [Non-steroidal anti-inflammatory agents (NSAID): when? how?].
    Grassi W; Pauri A
    Clin Ter; 1983 Jan; 104(2):143-50. PubMed ID: 6602684
    [No Abstract]   [Full Text] [Related]  

  • 34. [Oxyphenylbutazone rheumatologic practice].
    Casademont M
    Rev Esp Reum Enferm Osteoartic; 1966 Oct; 11(8):256-61. PubMed ID: 5301593
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inflammatory rheumatism and fundamentals of its drug therapy].
    Borkenstein E
    Wien Med Wochenschr; 1971 May; 121(22):449-52. PubMed ID: 5314609
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of rheumatic diseases with Supertendin].
    Iser H
    Med Welt; 1968 Oct; 43():2378-81. PubMed ID: 5712752
    [No Abstract]   [Full Text] [Related]  

  • 37. [Niflumic acid in rheumatology (100 cases)].
    Hawthorn E; Dumas M; Jauffret P
    Mars Med; 1968; 105(1):75-80. PubMed ID: 5310909
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of the properties of Ibuprofen in rheumatology].
    Recordier AM; Acquaviva P; Maestracci D; d' Omezon Y
    Mars Med; 1972; 109(9):593-9. PubMed ID: 4539217
    [No Abstract]   [Full Text] [Related]  

  • 39. [Compliance with anti-inflammatory therapy in rheumatologic pathology among outpatients. Value of single daily dose].
    Delcambre B
    Sem Hop; 1980 Oct 18-25; 56(39-40):1563-5. PubMed ID: 6255568
    [No Abstract]   [Full Text] [Related]  

  • 40. [Value of clofezone in the treatment of rheumatic diseases].
    Stroescu I; Stoicescu M; Dragomir M; Burtea A; Pintea G; Stoia I
    Schweiz Rundsch Med Prax; 1971 Feb; 60(7):217-20. PubMed ID: 5555631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.